 |
|
|
 |
|
Estrogen May Help Men's Hearts
|
 |  |  |  | Related Healthscout Videos |  |
|
Page: << Prev | 1 | 2 During the three-year follow-up period, 171 of the men died. When the researchers separated the men into groups based on their estrogen levels, they found that those with the lowest and highest levels of estrogen were more likely to have died.
The group with the lowest estrogen levels had a 44.6 percent survival rate, and those with the second-lowest scores had a 65.8 percent survival rate. The middle group had the highest survival rate, at 82.4 percent. The fourth group, which had elevated estrogen levels, had a 79 percent survival rate, and the group with the highest estrogen levels had a 63.6 percent survival rate.
"This is an interesting observation," said Dr. David Haines, chairman of cardiovascular medicine at Beaumont Hospital in Royal Oak, Mich. "But, it seems just as likely that it could be an epidemiological phenomenon."
Text Continues Below

Haines said that, based on the data from the study, he would not recommend supplementing heart failure patients with low estrogen, nor would he use medication to block the effects of estrogen on men with high levels.
"For something to be deadly at both ends is unlikely," said Dr. Stuart Katz, director of the heart failure program at the New York University Langone Medical Center in New York City. "Whenever you see this type of U-shaped relationship, it means there has to be two different explanations for what you've seen."
He said it's possible that estrogen may be a marker for worsening heart disease, but said it's probably not a more useful marker than those currently used. "I doubt this study will change what clinicians do," said Katz.
The three heart specialists agreed that though the study's observations raise interesting questions, much more research needs to be done before any changes in clinical practice might occur.
More information
Learn more about heart failure at HeartFailure.org.
Page: << Prev | 1 | 2
|
Copyright © 2009 ScoutNews, LLC. All rights reserved.
Last updated 5/12/2009
|
 |

SOURCES: Stephen Siegel, M.D., cardiologist, New York University Langone Medical Center, and clinical assistant professor, New York University School of Medicine, New York City; David Haines, M.D., chairman, Department of Cardiovascular Medicine, Beaumont Hospital, Royal Oak, Mich.; Stuart Katz, M.D., professor, medicine, Division of Cardiology, New York University School of Medicine, and director, Heart Failure Program, New York University Langone Medical Center, New York City; May 13, 2009, Journal of the American Medical Association
|